For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251118:nRSR0199Ia&default-theme=true
RNS Number : 0199I NatWest Group plc 18 November 2025
18 November 2025
NatWest Group plc
INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE
REGULATION
1. NatWest Group plc (the Company) announces that the PDMR set out below
purchased ordinary shares of £1.0769* each in the Company (Shares)
(ISIN:GB00BM8PJY71) on 17 November 2025 at the price indicated:
Name of PDMR Position of PDMR No. of Shares purchased Price of Shares purchased
Joshua Critchley Independent non-executive director 16,000 £5.9840
This transaction took place on the London Stock Exchange (XLON).
2. The Company announces that options to acquire Shares were granted to
PDMRs on 14 November 2025 under the NatWest Group plc 2017 UK ShareSave Plan
(the Plan) with an option price of £4.6688 per Share, as set out below.
Name of PDMR Position of PDMR No. of options granted Options exercisable from
Solange Chamberlain CEO, Retail Banking 781 18 December 2028
James Holian Chief Customer & Operations Officer 781 18 December 2028
Maria Kokkinou Chief People Officer 1,317 18 December 2030
Both Solange Chamberlain and James Holian chose a 3 year savings contract and
Maria Kokkinou chose a 5 year savings contract, in accordance with the rules
of the Plan.
These transactions took place outside of a trading venue.
* Note: the nominal value of ordinary shares without rounding is
£1.076923076923077 per share
Legal Entity Identifier: 2138005O9XJIJN4JPN90
For further information contact:
NatWest Group Investor Relations
Claire Kane
Director of Investor Relations
+44 20 7672 1758
NatWest Group Media Relations
+44(0)131 523 4205
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFFIFEAEISESF
Copyright 2019 Regulatory News Service, all rights reserved